Real world registry of use of SGLT2i in patients with HFrEF followed in a non-tertiary hospital.

13 May 2024 (14:42 - 15:51)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Virgilio Martinez Mateo

General Hospital La Mancha Centro, Alcazar de San Juan (Spain)

6 More presentations in this session

Presentation thumbnail

Challenging the norm: the use of sublingual nitroglycerin in patients with severe aortic stenosis undergoing cardiac CT

Doctor A. Silva (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Age differences in prescribing guideline-directed medical treatment in heart failure with mildly reduced and reduced ejection fraction

Doctor V. Lopes (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Adherence to the guideline-directed medical therapy in chronic heart failure: insight from a University Hospital

Doctor M. Assamti (Oujda, MA)

Abstract Slides Video

Presentation thumbnail

Prescribing SGLT2 inhibitors in acute heart failure: considerations for dysglycemia status, heart failure phenotype, and kidney function

Doctor A. Amanova (Aktobe, KZ)

Abstract Slides Video

Presentation thumbnail

Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.

Doctor V. De Simone (Legnago, IT)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in interventional cardiology and pharmacology 2

The Event

Event poster

Heart Failure 2024

13 May 2024 14:42 CET

You may be interested in

Congress Presentation

The impact of early SGLT2i inclusion in quadruple therapy for de novo patients: enhancing medication management and clinical outcomes

Congress Presentation

The impact of early SGLT2i inclusion in quadruple therapy for de novo patients: enhancing medication management and clinical outcomes

Congress Presentation

Did we forget ARNI in the era of SGLTi?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources